Holen Sie sich die Stockscreener-App
438.94
3.29%
14.00
Handel nachbörslich:
437.00
-1.94
-0.44%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 - PR Newswire
Amgen (AMGN) and AstraZeneca Report Positive Phase 3 Trial Resul - GuruFocus
From Discovery to Delivery: 5 Ways Amgen Is Putting Sustainability into Practice - www.marketscreener.com
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study - Benzinga
Amgen, AstraZeneca report phase 3 results for Tezspire in eosinophilic esophagitis - Seeking Alpha
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial - Reuters
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS - Amgen
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Dona’s Story: Strengthening Her Bones After a Postmenopausal Osteoporosis Diagnosis - Amgen
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group - MarketBeat
Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN - MarketBeat
Mattel appoints Amgen's Peter Griffith as CFO, succeeding Paul Ruh - Reuters
Migraine Market is Expected to Expand at 6% Growth Rate by 2036, Owing to the Development of Novel Mechanisms beyond CGRP, including PACAP-targeted Therapies, TRPA1 Antagonists, and Next-generation Neuromuscular Approaches | DelveInsight - GlobeNewswire Inc.
Amgen Has the Drugs and the Dividend. Now It Needs the Growth - Yahoo Finance
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen Inc. $AMGN Stock Sold by First Bank & Trust - MarketBeat
2,560 Amgen Inc. $AMGN Shares Sold by Generali Investments Management Co LLC - MarketBeat
Beat the Market the Zacks Way: Valero Energy, Hagerty, Palantir in Focus - Zacks Investment Research
Amgen Inc. $AMGN Position Lifted by IFP Advisors Inc - MarketBeat
Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc. - MarketBeat
Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings - MarketBeat
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider - Zacks Investment Research
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Can RARE's Approved Product Portfolio Drive Its Next Growth Phase? - Zacks Investment Research
J&J Q3 Earnings Beat Estimates, Sales Miss, View Raised, Stock Down - Zacks Investment Research
Here's Why Amgen (AMGN) is a Strong Momentum Stock - Zacks Investment Research
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH? - The Motley Fool
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? - The Motley Fool
Amgen (AMGN) Laps the Stock Market: Here's Why - Zacks Investment Research
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens - The Motley Fool
J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold? - Zacks Investment Research
Stock Market News for Oct 8, 2026 - Zacks Investment Research
Amgen (AMGN) Advances While Market Declines: Some Information for Investors - Zacks Investment Research
Can Amgen (NASDAQ:AMGN) Win With Direct-to-Patient Access Programs? - Kalkine Media
3,524 Amgen Inc. $AMGN Shares Sold by Colton Groome Financial Advisors LLC - MarketBeat
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance UK
Amgen Inc. $AMGN Shares Purchased by MassMutual Private Wealth & Trust FSB - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Ferguson Wellman Capital Management Inc. - MarketBeat
2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC - MarketBeat
AMGEN INC. R (AMG.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $400 By Investing.com - Investing.com India
Is AMGN Overvalued? DCF Says Worth $189 - GuruFocus
Amgen Inc Stock Futures,Dec-202 (SAMGN=F) Interactive Stock Chart - Yahoo! Finance Canada
Amgen Inc. $AMGN Shares Sold by CX Institutional - MarketBeat
Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch
Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock - benzinga.com
Amgen Inc. (AMGN34.SA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Amgen Inc Investor Call At IASLC 2019 World Conference on Lung Cancer Transcript - GuruFocus
2.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):